| Literature DB >> 29843706 |
Joung-Won Lee1,2, Nam-Kyoo Lim1, Hyun-Young Park3.
Abstract
BACKGROUND: Screening for risk of type 2 diabetes mellitus (T2DM) is an important public health issue. Previous studies report that fasting plasma glucose (FPG) and triglyceride (TG)-related indices, such as lipid accumulation product (LAP) and the product of fasting glucose and triglyceride (TyG index), are associated with incident T2DM. We aimed to evaluate whether FPG or TG-related indices can improve the predictive ability of a diabetes risk model for middle-aged Koreans.Entities:
Keywords: Risk model; TyG index; Type 2 diabetes mellitus
Mesh:
Substances:
Year: 2018 PMID: 29843706 PMCID: PMC5975474 DOI: 10.1186/s12902-018-0259-x
Source DB: PubMed Journal: BMC Endocr Disord ISSN: 1472-6823 Impact factor: 2.763
Characteristics of the study population at baseline
| Variables | Men | Women |
|
|---|---|---|---|
| ( | ( | ||
| Age, years | 51.4 ± 8.6 | 52.0 ± 8.9 | 0.0011 |
| Current Smoker, n(%) | 1753 (48.2) | 142 (3.5) | <.0001 |
| Current Drinker, n(%) | 2580 (71.0) | 1085 (26.7) | <.0001 |
| Hypertension, n(%) | 1074 (29.5) | 1101 (27.0) | 0.0149 |
| Family history of diabetes, n(%) | 333 (9.2) | 449 (11.0) | 0.0067 |
| Regular exercise, n(%) | 1712 (47.1) | 1654 (40.6) | <.0001 |
| BMI, kg/m2 | 24.1 ± 2.9 | 24.7 ± 3.2 | <.0001 |
| WC, cm | 83.3 ± 7.6 | 81.2 ± 9.5 | <.0001 |
| TG, mg/dl | 170.8 ± 111.6 | 140.9 ± 75.6 | <.0001 |
| TyG index | 8.7 ± 0.5 | 8.5 ± 0.5 | <.0001 |
| LAP | 38.1 ± 34.0 | 39.0 ± 30.6 | 0.1925 |
| SBP, mmHg | 121.2 ± 16.6 | 119.9 ± 19.1 | 0.0029 |
| DBP, mmHg | 81.6 ± 10.8 | 78.5 ± 11.6 | <.0001 |
| FPG, mg/dl | 84.5 ± 9.0 | 81.1 ± 7.7 | <.0001 |
| 2hPG, mg/dl | 110.5 ± 32.0 | 117.2 ± 28.3 | <.0001 |
| Total cholesterol, mg/dl | 190.3 ± 34.6 | 188.9 ± 33.9 | 0.0670 |
| HDL-C, mg/dl | 43.8 ± 10.0 | 46.0 ± 10.0 | <.0001 |
| LDL-C, mg/dl | 112.4 ± 34.2 | 114.7 ± 30.7 | 0.0017 |
| HbA1c, mg/dl | 5.6 ± 0.3 | 5.5 ± 0.4 | 0.1636 |
P values are from t-tests or chi-square tests for analysis of variance for continuous variables and categorical variables
Abbreviations: BMI body mass index, WC waist circumference, TG triglycerides; TyG index, the product of fasting glucose and triglycerides; LAP lipid accumulation product, SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, HDL-C high-density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, HbA glycated hemoglobin
Number of incident type 2 diabetes cases according to the quartiles for each measure
| Categories | Men (n = 3636) | Women (n = 4072) | ||
|---|---|---|---|---|
| Quartile | Diabetes (%) | Quartile | Diabetes (%) | |
| WC (cm) | Q1 (< 78.0) | 143 (16.4) | Q1 (< 74.0) | 128 (13.4) |
| Q2 (78.0–83.2) | 162 (17.6) | Q2 (74.0–80.6) | 198 (18.1) | |
| Q3 (83.3–88.2) | 207 (22.3) | Q3 (80.7–87.8) | 222 (22.2) | |
| Q4 (≥88.3) | 254 (27.7) | Q4 (≥87.9) | 249 (24.5) | |
| TG (mg/dl) | Q1 (< 106.0) | 137 (15.2) | Q1 (< 92.5) | 126 (12.4) |
| Q2 (106.0–142.9) | 167 (18.4) | Q2 (92.5–121.9) | 136 (13.6) | |
| Q3 (143.0–200.9) | 196 (21.5) | Q3 (122.0–165.9) | 225 (21.9) | |
| Q4 (≥201.0) | 266 (29.0) | Q4 (≥166.0) | 310 (30.3) | |
| FPG (mg/dl) | Q1 (< 78.0) | 106 (12.9) | Q1 (< 76.0) | 133 (13.9) |
| Q2 (78.0–82.9) | 132 (14.7) | Q2 (76.0–79.9) | 143 (16.3) | |
| Q3 (83.0–89.9) | 190 (19.5) | Q3 (80.0–84.9) | 206 (18.3) | |
| Q4 (≥90.0) | 338 (35.9) | Q4 (≥85.0) | 315 (28.4) | |
| LAP | Q1 (< 16.7) | 137 (15.1) | Q1 (< 18.8) | 126 (12.4) |
| Q2 (16.7–29.4) | 140 (15.4) | Q2 (18.8–30.7) | 167 (16.4) | |
| Q3 (29.5–49.1) | 212 (23.3) | Q3 (30.8–50.1) | 190 (18.7) | |
| Q4 (≥49.2) | 277 (30.5) | Q4 (≥50.2) | 314 (30.8) | |
| TyG index | Q1 (< 8.4) | 121 (13.3) | Q1 (< 8.2) | 113 (11.1) |
| Q2 (8.4–8.6) | 153 (16.8) | Q2 (8.2–8.4) | 140 (13.8) | |
| Q3 (8.7–9.0) | 206 (22.7) | Q3 (8.5–8.7) | 229 (22.5) | |
| Q4 (≥9.1) | 286 (31.5) | Q4 (≥8.8) | 315 (30.9) | |
Abbreviations: WC waist circumference, TG triglycerides, FPG fasting plasma glucose, LAP lipid accumulation product, TyG index the product of fasting glucose and triglycerides
The area under the ROC curve (AROC) and cut-off points for indices to predict type 2 diabetes
| Index | AROC (95% CI) | Cut-off point | Sensitivity (%) | Specificity (%) | Youden index |
|---|---|---|---|---|---|
| Men | |||||
| WC (cm) | 0.579 (0.563–0.595) | 84.00 | 56.01 | 57.11 | 0.13 |
| TG (mg/dl) | 0.592 (0.576–0.608) | 172.00 | 46.74 | 67.84 | 0.15 |
| FPG (mg/dl) | 0.660 (0.645–0.676) | 87.00 | 51.31 | 72.89 | 0.24 |
| LAP | 0.602 (0.586–0.618) | 30.50 | 62.79 | 55.54 | 0.18 |
| TyG index | 0.623 (0.607–0.638) | 8.86 | 52.09 | 66.59 | 0.19 |
| Women | |||||
| WC (cm) | 0.576 (0.561–0.592) | 78.17 | 69.26 | 43.54 | 0.13 |
| TG (mg/dl) | 0.627 (0.612–0.642) | 122.00 | 66.37 | 54.41 | 0.21 |
| FPG (mg/dl) | 0.599 (0.584–0.614) | 84.00 | 39.52 | 75.69 | 0.15 |
| LAP | 0.623 (0.607–0.637) | 35.84 | 57.59 | 61.59 | 0.19 |
| TyG index | 0.644 (0.629–0.659) | 8.52 | 67.25 | 55.85 | 0.23 |
Abbreviations: AROC area under the receiver operating characteristic curve, WC waist circumference, TG triglycerides, FPG fasting plasma glucose, LAP lipid accumulation product, TyG index, the product of fasting glucose and triglycerides
Multiple logistic regression analyses for each measure in predicting type 2 diabetes (odds ratios and 95% confidence intervals)
| Categories | Unadjusted | Adjusteda) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| WC | TG | FPG | LAP | TyG index | WC | TG | FPG | LAP | TyG index | |
| ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | |
| Men | ||||||||||
| Q1 | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
| Q2 | 1.09 (0.85–1.39) | 1.26 (0.99–1.62) | 1.16 (0.88–1.53) | 1.03 (0.79–1.33) | 1.32 (1.02–1.70) | 1.07 (0.81–1.40) | 1.21 (0.94–1.55) | 1.18 (0.89–1.56) | 1.04 (0.79–1.36) | 1.26 (0.97–1.64) |
| Q3 | 1.46 (1.15–1.85) | 1.54 (1.21–1.95) | 1.64 (1.27–2.12) | 1.71 (1.35–2.18) | 1.91 (1.49–2.45) | 1.35 (1.00–1.83) | 1.39 (1.08–1.79) | 1.68 (1.29–2.19) | 1.70 (1.28–2.25) | 1.82 (1.41–2.36) |
| Q4 | 1.95 (1.55–2.46) | 2.29 (1.82–2.88) | 3.78 (2.96–4.82) | 2.47 (1.96–3.11) | 2.99 (2.36–3.79) | 1.64 (1.13–2.38) | 2.03 (1.59–2.61) | 3.85 (2.99–4.97) | 2.47 (1.82–3.34) | 2.79 (2.16–3.60) |
| Women | ||||||||||
| Q1 | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
| Q2 | 1.43 (1.12–1.82) | 1.11 (0.86–1.44) | 1.20 (0.93–1.55) | 1.39 (1.08–1.78) | 1.28 (0.98–1.66) | 1.14 (0.88–1.48) | 1.02 (0.78–1.33) | 1.18 (0.91–1.53) | 1.26 (0.97–1.64) | 1.19 (0.91–1.55) |
| Q3 | 1.86 (1.46–2.36) | 1.98 (1.56–2.51) | 1.38 (1.09–1.75) | 1.63 (1.27–2.07) | 2.32 (1.82–2.97) | 1.27 (0.95–1.69) | 1.69 (1.32–2.16) | 1.32 (1.04–1.68) | 1.35 (1.03–1.78) | 1.97 (1.53–2.53) |
| Q4 | 2.10 (1.66–2.66) | 3.07 (2.44–3.87) | 2.45 (1.95–3.06) | 3.15 (2.51–3.97) | 3.59 (2.83–4.55) | 1.17 (0.83–1.65) | 2.42 (1.90–3.08) | 2.15 (1.71–2.71) | 2.44 (1.82–3.26) | 2.85 (2.22–3.66) |
a)Adjusted for age, body mass index, status of hypertension, family history of diabetes, smoking status, alcohol consumption, and regular exercise
Abbreviations: ORs odds ratios, WC waist circumference, TG triglycerides, FPG fasting plasma glucose, LAP lipid accumulation product, TyG index, the product of fasting glucose and triglycerides
Reclassification and discrimination results associated with the risk prediction of incident type 2 diabetes according to each measure
| Parameter | Men | Women | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AROC | cNRI | IDI | AROC | cNRI | IDI | |||||||
| Basic modela) | 0.615 | 0.621 | ||||||||||
| Basic model + WC | 0.619 | 0.1176 | 0.056 | 0.1689 | 0.002 | 0.0140 | 0.621 | 0.3233 | −0.023 | 0.5666 | 0.000 | 1.0000 |
| Basic model + TG | 0.632 | <.0001 | 0.227 | <.0001 | 0.007 | <.0001 | 0.652 | <.0001 | 0.286 | <.0001 | 0.019 | <.0001 |
| Basic model + FPG | 0.692 | <.0001 | 0.480 | <.0001 | 0.064 | <.0001 | 0.652 | <.0001 | 0.214 | <.0001 | 0.018 | <.0001 |
| Basic model + LAP | 0.634 | <.0001 | 0.236 | <.0001 | 0.007 | <.0001 | 0.644 | <.0001 | 0.213 | <.0001 | 0.016 | <.0001 |
| Basic model + TyG index | 0.656 | <.0001 | 0.387 | <.0001 | 0.023 | <.0001 | 0.666 | <.0001 | 0.360 | <.0001 | 0.029 | <.0001 |
a)Basic model: age, body mass index, status of hypertension, family history of diabetes, smoking status, alcohol consumption, and regular exercise
*P-value for AROC means vs. Basic model
Abbreviations: AROC area under the receiver operating characteristic curve, WC waist circumference, TG triglycerides, LAP lipid accumulation product, TyG index the product of fasting glucose and triglycerides, cNRI continuous net reclassification improvement, IDI Integrated Discrimination Improvement
Multiple logistic regression analyses for cutoff-points of TyG index in predicting type 2 diabetes (odds ratios and 95% confidence intervals)
| Cutoff-points | Men | Women | ||
|---|---|---|---|---|
| Unadjusted | Adjusteda) | Unadjusted | Adjusteda) | |
| ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | |
| TyG index ≥8.8b) | 2.05 (1.75–2.41) | 1.93 (1.62–2.29) | 2.41 (2.05–2.83) | 2.03 (1.71–2.41) |
| TyG index ≥8.86/8.52c) | 2.13 (1.82–2.51) | 2.01 (1.69–2.39) | 2.57 (2.18–3.02) | 2.16 (1.82–2.56) |
a)Adjusted for age, body mass index, status of hypertension, family history of diabetes, smoking status, alcohol consumption, and regular exercise, b)TyG index ≥8.8 cm, Lee et al. [42], c)TyG index ≥8.86 cm for men ≥8.52 for women in the present study
Abbreviations: ORs odds ratios; TyG index, the product of fasting glucose and triglycerides
Multiple logistic regression analyses for each MetS component in predicting type 2 diabetes (odds ratios and 95% confidence intervals)
| Components of MetSa) | Men | Women | ||
|---|---|---|---|---|
| Unadjusted | Adjusted h) | Unadjusted | Adjusted h) | |
| ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | ORs (95% CI) | |
| Central obesityb) | 1.71 (1.42–2.06) | 1.35 (1.10–1.65) | 1.56 (1.33–1.83) | 1.16 (0.97–1.38) |
| Elevated TGc) | 1.70 (1.45–2.00) | 1.57 (1.31–1.87) | 2.26 (1.93–2.64) | 1.90 (1.60–2.26) |
| Low HDL-Cd) | 1.14 (0.96–1.34) | 1.01 (0.84–1.22) | 1.53 (1.28–1.83) | 1.21 (1.00–1.47) |
| Elevated FPGe) | 5.43 (4.09–7.21) | 5.16 (3.85–6.92) | 3.65 (2.39–5.57) | 3.55 (2.29–5.50) |
| Elevated BPf) | 1.79 (1.52–2.10) | 1.47 (1.24–1.75) | 1.65 (1.41–1.93) | 1.29 (1.09–1.54) |
| MetSg) | 2.22 (1.86–2.66) | 2.24 (1.87–2.69)i) | 2.22 (1.88–2.61) | 2.03 (1.70–2.41)i) |
a)Modified NCEP-ATP III criteria [47] with the Korean cut-off for WC, b)WC ≥ 90 cm for men ≥85 for women, Lee et al. [48], c)TG ≥ 150 mg/dl, d)HDL-C < 40 mg/dl for men < 50 mg/dl for women, e)FPG ≥ 100 mg/dl, f)Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg, g)Number of MetS components ≥3, h)Adjusted for other components of MetS, age, family history of diabetes, smoking status, alcohol consumption, and regular exercise, i)Adjusted for age, family history of diabetes, smoking status, alcohol consumption, and regular exercise
Abbreviations: MetS Metabolic syndrome, ORs odds ratios, TG triglyceride, HDL-C high-density lipoprotein cholesterol, FPG fasting plasma glucose, BP blood pressure, WC, waist circumference
The area under the ROC curve (AROC) for indices to predict type 2 diabetes stratified by MetS components
| MetS componentsa) | Central obesityb) | Elevated TGc) | Low HDL-Cd) | Elevated FPGe) | Elevated BPf) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Subgroup | No | Yes | No | Yes | No | Yes | No | Yes | No | Yes |
| Index | AROC | AROC | AROC | AROC | AROC | AROC | AROC | AROC | AROC | AROC |
| Men | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( |
| WC | 0.553 | 0.532 | 0.535 | 0.569 | 0.570 | 0.584 | 0.571 | 0.573 | 0.565 | 0.559 |
| TG | 0.589 | 0.534 | 0.546 | 0.559 | 0.598 | 0.574 | 0.588 | 0.591 | 0.572 | 0.588 |
| FPG | 0.648 | 0.680 | 0.637 | 0.676 | 0.661 | 0.666 | 0.621 | 0.506 | 0.649 | 0.661 |
| LAP | 0.584 | 0.537 | 0.546 | 0.582 | 0.598 | 0.599 | 0.595 | 0.604 | 0.582 | 0.591 |
| TyG index | 0.618 | 0.569 | 0.605 | 0.607 | 0.631 | 0.605 | 0.607 | 0.586 | 0.602 | 0.620 |
| Women | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( |
| WC | 0.556 | 0.519 | 0.536 | 0.564 | 0.520 | 0.583 | 0.576 | 0.506 | 0.570 | 0.545 |
| TG | 0.610 | 0.626 | 0.567 | 0.559 | 0.611 | 0.622 | 0.629 | 0.596 | 0.614 | 0.621 |
| FPG | 0.590 | 0.598 | 0.581 | 0.617 | 0.550 | 0.616 | 0.586 | 0.566 | 0.598 | 0.587 |
| LAP | 0.601 | 0.625 | 0.553 | 0.590 | 0.565 | 0.630 | 0.623 | 0.570 | 0.608 | 0.609 |
| TyG index | 0.628 | 0.643 | 0.595 | 0.596 | 0.621 | 0.643 | 0.641 | 0.597 | 0.633 | 0.634 |
a)Modified NCEP-ATP III criteria [47] with the Korean cut-off for WC, b)WC ≥ 90 cm for men ≥85 for women, Lee et al. [48], c)TG ≥ 150 mg/dl, d)HDL-C < 40 mg/dl for men < 50 mg/dl for women, e)FPG ≥ 100 mg/dl, f) Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg
Abbreviations: MetS Metabolic syndrome, TG triglyceride, HDL-C high-density lipoprotein cholesterol, FPG fasting plasma glucose, BP blood pressure, AROC area under the receiver operating characteristic curve, WC waist circumference, LAP lipid accumulation product, TyG index, the product of fasting glucose and triglycerides